Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer Journal Article


Authors: Herr, H. W.; Donat, S. M.; Bajorin, D. F.
Article Title: Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer
Abstract: Purpose: We update our experience with post-chemotherapy surgery in patients with unresectable or lymph node positive bladder cancer. Methods: Of 207 patients with unresectable or regionally metastatic bladder cancer 80 (39%) underwent post-chemotherapy surgery after treatment with a cisplatin based chemotherapy regimen. We assessed the impact of surgery on achieving a complete response to chemotherapy and on relapse-free survival. Results: No viable cancer was present at post-chemotherapy surgery in 24 of the 80 cases (30%), pathologically confirming a complete response to chemotherapy. Of the 24 patients 14 (58%) survived 9 months to 5 years. Residual viable cancer was completely resected in 49 patients (61%), resulting in a complete response to chemotherapy plus surgery, and 20 (41%) survived. Post-chemotherapy surgery did not benefit those who failed to achieve a major complete or partial response to chemotherapy. Only 1 of the 12 patients (8%) who refused surgery remains alive. Conclusions: Post-chemotherapy surgical resection of residual cancer may result in disease-free survival in some patients who would otherwise die of disease. Optimal candidates include those in whom the pre-chemotherapy sites of disease are restricted to the bladder and pelvis or regional lymph nodes, and who have a major response to chemotherapy.
Keywords: cancer chemotherapy; cancer survival; cancer surgery; major clinical study; cisplatin; combined modality therapy; treatment indication; metastasis; antineoplastic combined chemotherapy protocols; bladder cancer; urinary bladder neoplasms; neoplasm metastasis; drug therapy; carcinoma, transitional cell; bladder carcinoma; bladder; humans; human; male; female; priority journal; article
Journal Title: Journal of Urology
Volume: 165
Issue: 3
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 2001-03-01
Start Page: 811
End Page: 814
Language: English
PUBMED: 11176475
PROVIDER: scopus
DOI: 10.1016/S0022-5347(05)66533-0
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    657 Bajorin
  2. Sherri M Donat
    174 Donat
  3. Harry W Herr
    594 Herr